TrialPanorama/TrialPanorama-database huggingface dataset:
Study 36864830 — Predictive Biomarker (PRD): PSMB7 mRNA
Genes: PSMB7; Z
Study 36864892 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 36864892 — Surrogate Endpoint (SUR): Blood pressure
Study 36864892 — Surrogate Endpoint (SUR): Serum potassium
Study 36864979 — Surrogate Endpoint (SUR): Blood pressure
Study 36864985 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36865055 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 36865055 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 36865133 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 36865133 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 36865252 — Surrogate Endpoint (SUR): Blood pressure
Study 36865545 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 36866471 — Surrogate Endpoint (SUR): Blood pressure
Study 36866838 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 36866852 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study 36866852 — Predictive Biomarker (PRD): Anti-aquaporin-4 antibody
Study 36866921 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 36867758 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 36868525 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 36868599 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 36868914 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 36868990 — Predictive Biomarker (PRD): ABCB5 mRNA
Genes: ABCB5
Study 36869208 — Surrogate Endpoint (SUR): Blood pressure
Study 36869258 — Pharmacodynamic Biomarker (PDY): Error related negativity
Study 36869356 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 36869356 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36869794 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 36869793 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 36870093 — Predictive Biomarker (PRD): PCDH19 mRNA
Genes: PCDH19; KIAA1313
Study 36870360 — Predictive Biomarker (PRD): Microsatellite instability
Study 36870360 — Surrogate Endpoint (SUR): Pathological complete response
Study 36870436 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36870941 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 36870948 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study 36870948 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study 36870948 — Predictive Biomarker (PRD): FOXG1 mRNA
Genes: FOXG1; FKH2; FKHL1; FKHL2; FKHL3; FKHL4; FOXG1A; FOXG1B; FOXG1C
Study 36870947 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 36870947 — Predictive Biomarker (PRD): Microsatellite instability
Study 36871042 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 36871101 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 36871424 — Surrogate Endpoint (SUR): Pathological complete response
Study 36871487 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 36871487 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 36871573 — Surrogate Endpoint (SUR): Blood pressure
Study 36871574 — Predictive Biomarker (PRD): MBTPS1 mRNA
Genes: MBTPS1; KIAA0091; S1P; SKI1
Study 36872017 — Safety Biomarker (SAF): MTHFR
Study 36872016 — Predictive Biomarker (PRD): Hormone receptor
Study 36872181 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36872873 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 36873411 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 36873421 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36873425 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36873431 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study 36873431 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36873865 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 36873865 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36873868 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study 36873994 — Surrogate Endpoint (SUR): Blood pressure
Study 36875061 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36875114 — Predictive Biomarker (PRD): AIRE mRNA
Genes: AIRE; APECED
Study 36875669 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36875669 — Surrogate Endpoint (SUR): Blood pressure
Study 36876480 — Surrogate Endpoint (SUR): Blood pressure
Study 36876740 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36876740 — Surrogate Endpoint (SUR): Serum creatinine
Study 36876957 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 36877098 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 36877098 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 36877098 — Surrogate Endpoint (SUR): Blood pressure
Study 36877177 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 36877177 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 36877234 — Predictive Biomarker (PRD): ANO7 mRNA
Genes: ANO7; NGEP; PCANAP5; TMEM16G
Study 36877666 — Surrogate Endpoint (SUR): Forced vital capacity
Study 36877666 — Surrogate Endpoint (SUR): Blood pressure
Study 36877807 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36878239 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 36878311 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 36878326 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 36878326 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 36878326 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 36878326 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 36878722 — Predictive Biomarker (PRD): LAMB2 mRNA
Genes: LAMB2; LAMS
Study 36879012 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36879107 — Predictive Biomarker (PRD): CXCR5 mRNA
Genes: CXCR5; BLR1; MDR15
Study 36879107 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 36879129 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 36879424 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 36879424 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36879584 — Surrogate Endpoint (SUR): Probing pocket depth
Study 36880261 — Surrogate Endpoint (SUR): Blood pressure
Study 36880426 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36880426 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 36880426 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 36880945 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 36881032 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36881247 — Predictive Biomarker (PRD): LTA mRNA
Genes: LTA; TNFB; TNFSF1
Study 36881247 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36881820 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36881820 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study 36881820 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 36881820 — Predictive Biomarker (PRD): S100A8 mRNA
Genes: S100A8; CAGA; CFAG; MRP8
Study 36881820 — Predictive Biomarker (PRD): OSMR mRNA
Genes: OSMR; OSMRB
Study 36881820 — Predictive Biomarker (PRD): FCGR3A mRNA
Genes: FCGR3A; CD16A; FCG3; FCGR3; IGFR3
Study 36881820 — Predictive Biomarker (PRD): FCGR3B mRNA
Genes: FCGR3B; CD16B; FCG3; FCGR3; IGFR3
Study 36881820 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL6 mRNA
Genes: CXCL6; GCP2; SCYB6
Study 36882015 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 36882015 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 36882015 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 36882015 — Predictive Biomarker (PRD): CCL26 mRNA
Genes: CCL26; SCYA26; UNQ216/PRO242
Study 36882456 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36882456 — Predictive Biomarker (PRD): ACVR1 mRNA
Genes: ACVR1; ACVRLK2
Study 36882736 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36882736 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36882736 — Predictive Biomarker (PRD): Hormone receptor
Study 36882775 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 36882942 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study 36883141 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study 36883141 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study 36883141 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 36883417 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 36883420 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 36883573 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36883573 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study 36884247 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 36884302 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 36888928 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36888928 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 36889425 — Surrogate Endpoint (SUR): Serum creatinine
Study 36889610 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 36889610 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36889645 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 36889826 — Surrogate Endpoint (SUR): Serum potassium
Study 36890020 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 36890354 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 36890354 — Predictive Biomarker (PRD): Anti-acetylcholine receptor antibody
Study 36890354 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 36890393 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 36890526 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 36890535 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 36890601 — Surrogate Endpoint (SUR): Blood pressure
Study 36890688 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 36890688 — Predictive Biomarker (PRD): TIMP4 mRNA
Genes: TIMP4
Study 36891077 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 36891909 — Predictive Biomarker (PRD): TRIM63 mRNA
Genes: TRIM63; IRF; MURF1; RNF28; SMRZ
Study 36891909 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 36891979 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36891979 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 36891979 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 36892565 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 36892565 — Predictive Biomarker (PRD): Induced myeloid leukemia cell differentiation protein Mcl-1
Genes: MCL1; BCL2L3
Study 36892676 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 36892707 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 36892745 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 36892745 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36892847 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 36892847 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36892847 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 36893453 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 36893453 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 36893453 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36893777 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36893777 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36894249 — Surrogate Endpoint (SUR): Blood pressure
Study 36894565 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 36894877 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study 36894921 — Surrogate Endpoint (SUR): Blood pressure
Study 36894938 — Surrogate Endpoint (SUR): Blood pressure
Study 36894940 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 36895062 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36895330 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study 36897127 — Monitoring Biomarker (MOI): Cell-free DNA
Study 36897140 — Predictive Biomarker (PRD): MME mRNA
Genes: MME; EPN
Study 36897140 — Surrogate Endpoint (SUR): Serum creatinine
Study 36897180 — Surrogate Endpoint (SUR): Bone mineral density
Study 36897251 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 36897427 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 36897427 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 36897544 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 36897799 — Surrogate Endpoint (SUR): Blood pressure
Study 36897834 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36898233 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36898233 — Predictive Biomarker (PRD): Hormone receptor
Study 36898363 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 36898393 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36898391 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36898606 — Predictive Biomarker (PRD): FBP1 mRNA
Genes: FBP1; FBP
Study 36898767 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 36899125 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study 36899369 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 36899369 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 36900802 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 36900802 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 36902536 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 36902798 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 36902798 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 36905161 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36905198 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 36905198 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study 36905347 — Surrogate Endpoint (SUR): Blood pressure
Study 36905441 — Surrogate Endpoint (SUR): Blood pressure
Study 36905528 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36905771 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36905771 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 36905771 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 36905771 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 36905771 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 36905771 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 36906440 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 36906660 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study 36906664 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 36906875 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36907947 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 36908150 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36908150 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 36908503 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36908609 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study 36908619 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 36910109 — Surrogate Endpoint (SUR): Pathological complete response
Study 36910518 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 36910518 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study 36910518 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study 36911725 — Safety Biomarker (SAF): Arginase-1
Genes: ARG1
Study 36911725 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 36911725 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study 36911944 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study 36911951 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 36912445 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36912445 — Safety Biomarker (SAF): IL-6 and IL-10
Study 36912538 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 36913051 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 36913051 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36913694 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 36914185 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 36914193 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 36914946 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36915009 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study 36915009 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 36915146 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 36915182 — Surrogate Endpoint (SUR): Blood pressure
Study 36915199 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36915284 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 36917123 — Surrogate Endpoint (SUR): Serum calcium
Study 36917594 — Predictive Biomarker (PRD): IPP mRNA
Genes: IPP; KLHL27
Study 36917594 — Pharmacodynamic Biomarker (PDY): Human leukocyte antigen DR
Study 36918388 — Surrogate Endpoint (SUR): Serum creatinine
Study 36918949 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36919122 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36919398 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36919398 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 36919514 — Predictive Biomarker (PRD): AMPH mRNA
Genes: AMPH; AMPH1
Study 36919514 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study 36920122 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study 36920122 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 36920449 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 36920449 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 36920652 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 36920755 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study 36920778 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 36921289 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 36921494 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 36921494 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 36921494 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 36921804 — Surrogate Endpoint (SUR): Serum triglycerides
Study 36922042 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 36922497 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 36922497 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 36922497 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 36922864 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 36922936 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study 36923305 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 36923454 — Predictive Biomarker (PRD): HMGCR mRNA
Genes: HMGCR
Study 36923454 — Predictive Biomarker (PRD): UCN2 mRNA
Genes: UCN2; SRP; URP
Study 36923454 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 36923556 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study 36923571 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 36923684 — Surrogate Endpoint (SUR): Blood pressure
Study 36924196 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study 36924196 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study 36924196 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 36924196 — Predictive Biomarker (PRD): NTRK